Sahlgrenska University Hospital
Gothenburg, 41345, Sweden
NCT Number: NCT02987023
The study is a follow up of NCT01844362. Uterus transplantation will be performed from live donors to patients with uterine factor infertility. If will be performed before transplantation. Organ procurement from the donor will be performed by robotic assisted laparoscopy. Transplantation will be by laparotomy. Embryo transfer will be done 10-12 months after transplantation. After birth of 1-3 children the uterus will be removed by hysterectomy,
Looking for future studies?
Notify Me20 year–38 year
Female
Observational
Gothenburg, 41345, Sweden
The study is a follow up of NCT01844362. Uterus transplantation will be performed from live donors to patients with uterine factor infertility. If will be performed before transplantation. Organ procurement from the donor will be performed by robotic assisted laparoscopy. Transplantation will be by laparotomy. Embryo transfer will be done 10-12 months after transplantation. After birth of 1-3 children the uterus will be removed by hysterectomy.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Uterus transplantation from live donor
Time frame: 5 years
Assessed by records from birthing unit and Swedish National Birth registry
Time frame: 8 years
Assessed by growth parameters and neuropsychiatric tests (Bayley Mental Scale, M-CHAT, CBCL, WPPSI-IV)
Sahlgrenska University Hospital
Other
Acronym: UTX-robot
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03712982
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Waltham, Massachusetts, United States
View Trial DetailsNCT07288866
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Clermont-Ferrand, Auvergne, France
View Trial DetailsNCT03703700
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT05076032
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Olomouc, Czechia
View Trial Details